Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome

NCT00977132 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped delayed recruitment

Conditions

Myelodysplastic Syndrome MDS

Interventions

DRUG: Valproic aicd
DRUG: Lenalidomide

Sponsor

Heinrich-Heine University, Duesseldorf